SXTC China SXT Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 1, 2026
$2.41
· of 52w range
· above low
· to high
$1.7852w low
$83760.0052w high
Market Cap
$2M
P/E
-0.3
EPS
$-9.13
Revenue
$1M
your badges
52W Range
$2–$83760
Analyst Rating
·
Price Target
·
P/E
-0.3
ROE
-27.5%
Net Profit Margin
-545.2%
Your badge strip is empty — pin a metric anywhere on this page.
SXTC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.41
Market Cap
$2M
P/E
-0.3
EPS
$-9.13
Revenue
$1M
ROE
-27.5%
Debt/Equity
0.0
52W Range
$2–$83760
SXTC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Aug. 10, 2026 | 1-for-80 | Reverse |
| Feb. 3, 2026 | 1-for-150 | Reverse |
| Oct. 5, 2023 | 1-for-25 | Reverse |
| Feb. 22, 2021 | 1-for-4 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$1M2017-03-31 → 2026-03-31
EPS$-9.132017-03-31 → 2026-03-31
Free Cash Flow·2019-03-31 → 2020-03-31
Net margin-545.2%2019-03-31 → 2026-03-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | SXTC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.35Y avg ≈-0.1 | ≈-0.1 | · | · | |
| P/S | 2.05Y avg ≈13.9 | ≈13.9 | · | · | |
| P/B | 0.15Y avg ≈1.8 | ≈1.8 | · | · | |
| EV / EBITDA | 3.55Y avg ≈-2.3 | ≈-2.3 | · | · | |
| Price / Cash Flow | -0.65Y avg ≈-193.8 | ≈-193.8 | · | · | |
| EV / Revenue | -21.95Y avg ≈3.1 | ≈3.1 | · | · | |
| Price / Tangible Book | 0.15Y avg ≈1.8 | ≈1.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | SXTC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 21.9%5Y avg ≈28.3% | ≈28.3% | · | · | |
| Operating Margin | -625.9%5Y avg ≈-278.8% | ≈-278.8% | · | · | |
| EBITDA Margin | -619.4%5Y avg ≈-269.5% | ≈-269.5% | · | · | |
| Pretax Margin | -545.2%5Y avg ≈-275.9% | ≈-275.9% | · | · | |
| Net Profit Margin | -545.2%5Y avg ≈-283.4% | ≈-283.4% | · | · | |
| ROA | -22.0%5Y avg ≈-16.8% | ≈-16.8% | · | · | |
| ROE | -27.5%5Y avg ≈-29.1% | ≈-29.1% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | SXTC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.05Y avg ≈0.0 | ≈0.0 | · | · | |
| Current Ratio | 7.95Y avg ≈3.1 | ≈3.1 | · | · | |
| Quick Ratio | 6.75Y avg ≈2.8 | ≈2.8 | · | · | |
| Long-Term Debt / Equity | 0.05Y avg ≈0.0 | ≈0.0 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | SXTC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.05Y avg ≈0.1 | ≈0.1 | · | · | |
| Inventory Turnover | 1.15Y avg ≈1.7 | ≈1.7 | · | · | |
| Receivables Turnover | 1.05Y avg ≈1.1 | ≈1.1 | · | · | |
| Revenue / Employee | ≈$20.3K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $2M | $2M | $3M | $5M | $5M | $7M | $7M | |
| Cost of Revenue | $889.4K | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $4M | |
| Gross Profit | $248.7K | $367.4K | $554.0K | $426.3K | $1M | $3M | $3M | $5M | $3M | |
| R&D Expense | · | · | $184.2K | $200.7K | $367.0K | · | · | · | · | |
| SG&A Expense | $7M | $3M | $3M | $6M | $6M | $3M | $2M | $1M | $1M | |
| Operating Expenses | $7M | $3M | $3M | $6M | $6M | $5M | $4M | $3M | $2M | |
| Operating Income | $-7M | $-3M | $-3M | $-6M | $-5M | $-2M | $-1M | $2M | $2M | |
| Interest Expense | · | · | · | $476.8K | $36.7K | $2M | $3M | $5.2K | $779 | |
| Other Non-op | $917.8K | $-623.2K | $-583.3K | $-327.3K | $-218.3K | $871.6K | $-73.8K | $27.1K | $-3.8K | |
| Pretax Income | $-6M | $-3M | $-3M | $-6M | $-5M | $-3M | $-10M | $2M | $2M | |
| Income Tax | · | · | · | · | $328.1K | $-192.7K | $-101.7K | $252.2K | $440.1K | |
| Net Income | $-6M | $-3M | $-3M | $-6M | $-6M | $-3M | $-10M | $2M | $1M | |
| EPS (Basic) | $-9.13 | $-348.17 | $-4285.66 | $-177.84 | $-137.92 | $-3.82 | $33.28 | $0.07 | $0.06 | |
| EPS (Diluted) | $-9.13 | $-348.17 | $-4285.66 | $-177.84 | $-137.92 | $-3.82 | · | $0.07 | $0.06 | |
| Shares (Basic) | 679,648 | 9,489 | 723 | 33,372 | 41,591 | 719,549 | 309,108 | 20,568,630 | 20,000,000 | |
| Shares (Diluted) | 679,648 | 9,489 | 723 | 33,372 | 41,591 | 719,549 | · | 20,568,630 | 20,000,000 | |
| EBITDA | $-7M | $-3M | $-2M | $-5M | $-5M | $-2M | $-1M | $2M | · |
Balance Sheet
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $18M | $12M | $17M | $16M | $13M | $7M | $9M | $657.8K | |
| Receivables | $931.6K | $1M | $1M | $1M | $3M | $5M | $4M | $4M | $3M | |
| Inventory | $777.1K | $828.1K | $794.9K | $531.3K | $1M | $859.7K | $892.8K | $1M | $1M | |
| Prepaid Expense | $372.4K | $319.1K | $31.6K | $230.6K | $864.7K | $2M | $5M | $707.3K | $910.6K | |
| Current Assets | $35M | $21M | $14M | $20M | $22M | $23M | $20M | $16M | $6M | |
| PP&E (Net) | $117.1K | $178.6K | $328.8K | $962.2K | $1M | $1M | $2M | $1M | $862.5K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | · | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $745.4K | $599.6K | |
| Intangibles | $6.3K | $11.8K | $19.1K | $27.9K | $38.8K | $45.8K | $50.1K | $61.1K | $60.7K | |
| Total Assets | $35M | $22M | $23M | $30M | $34M | $35M | $22M | $17M | $8M | |
| Accounts Payable | $497.6K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| Short-term Debt | $355.2K | $702.2K | $493.1K | $167.5K | · | $37.1K | $43.9K | $27.8K | $385.1K | |
| Current Liabilities | $4M | $6M | $9M | $14M | $17M | $19M | $12M | $6M | $4M | |
| Capital Leases | · | · | · | $248.0K | · | · | · | · | · | |
| Total Liabilities | $5M | $6M | $9M | $15M | $17M | $19M | $12M | $6M | $4M | |
| Long-term Debt | · | $6M | $5M | $125.7K | · | $6.3K | $36.5K | $41.7K | · | |
| Total Debt | $999.6K | $807.2K | $631.5K | $293.2K | $11.4K | $37.1K | $43.9K | $233.3K | · | |
| Common Stock | $64M | $45M | $40M | $913.8K | $162.5K | $62.1K | $34.7K | $22.7K | $20.0K | |
| Paid-in Capital | · | · | · | $36M | $31M | $25M | $17M | $8M | $1M | |
| Retained Earnings | $-34M | $-28M | $-25M | $-22M | $-16M | $-10M | $-7M | $3M | $2M | |
| AOCI | $-197.9K | $-1M | $-1M | $-197.6K | $956.1K | $527.8K | $-590.7K | $50.4K | $257.4K | |
| Stockholders' Equity | $30M | $15M | $14M | $15M | $16M | $16M | $9M | $11M | $3M | |
| Liabilities + Equity | $35M | $22M | $23M | $30M | $34M | $35M | $22M | $17M | $8M | |
| Shares Outstanding | 958,081 | 91,756 | 1,849 | 381 | 10,157 | 31,050 | 8,666,928 | 22,706,701 | 20,000,000 |
Cash Flow
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $73.7K | $82.3K | $203.2K | $250.2K | $320.0K | $345.4K | $331.8K | $180.9K | $129.4K | |
| Stock-based Comp | $5M | · | $352.1K | $554.6K | $2M | · | · | · | · | |
| Deferred Tax | · | · | · | · | $328.1K | $-192.7K | $-101.7K | $-7.7K | $-5.9K | |
| Amort. of Intangibles | $5.8K | $7.2K | $7.5K | $7.9K | $8.5K | $8.0K | $8.0K | $7.0K | $6.2K | |
| Other Non-cash | $-3M | $876.0K | $615.1K | $6M | $5M | $1M | $11M | · | · | |
| Operating Cash Flow | $-4M | $-2M | $-2M | $-80.8K | $268.3K | $-1M | $934.2K | $239.2K | $2M | |
| CapEx | · | $2.0K | $7.1K | · | · | · | $130.8K | $535.8K | $436.0K | |
| Investing Cash Flow | $-1M | $63.5K | $26.4K | $-12.3K | $-46.9K | $-6M | $-5M | $-610.1K | $-1M | |
| Net Debt Issued | · | · | · | · | · | · | $-1M | $41.7K | · | |
| Stock Issued | · | · | · | · | $-30.0K | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $-30.0K | · | · | · | · | |
| Financing Cash Flow | $14M | $8M | $-3M | $3M | $2M | $12M | $3M | $9M | $-314.2K | |
| Net Change in Cash | $10M | $6M | $-5M | $2M | $2M | $6M | $-2M | $9M | $592.2K | |
| Taxes Paid | · | · | · | · | $16.7K | $5.5K | $287.8K | $1.5K | · | |
| Free Cash Flow | · | · | · | · | · | · | $803.4K | $-296.6K | · | |
| Levered FCF | · | · | · | · | · | · | $-3M | $-301.1K | · |
Profitability
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 21.9% | 21.1% | 28.7% | 21.6% | 48.1% | 59.4% | 52.4% | 65.8% | · | |
| Operating Margin | -625.9% | -154.0% | -130.4% | -284.4% | -199.4% | -46.0% | -26.0% | 25.2% | · | |
| Net Margin | -545.2% | -189.8% | -160.7% | -301.0% | -220.4% | -57.5% | -199.3% | 21.9% | · | |
| Pretax Margin | -545.2% | -189.8% | -160.7% | · | -207.8% | -61.6% | -201.3% | 25.6% | · | |
| EBITDA Margin | -619.4% | -149.2% | -119.9% | -271.7% | -187.1% | -38.8% | -19.6% | 25.2% | · | |
| ROA | -22.0% | -14.8% | -11.8% | -18.8% | -16.9% | -9.8% | -52.5% | 12.2% | · | |
| ROE | -27.5% | -22.5% | -21.6% | -38.6% | -35.4% | -21.7% | -100.3% | 21.4% | · | |
| ROIC | · | · | · | · | -33.5% | -12.8% | -14.1% | 13.4% | · |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 3.5 | 1.6 | 1.3 | 1.3 | 1.3 | 1.6 | 2.5 | · | |
| Quick Ratio | 6.7 | 3.2 | 1.5 | 1.3 | 1.1 | 1.0 | 0.9 | 2.1 | · | |
| Debt / Equity | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| LT Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | · | -11.8 | -141.4 | -1.4 | -0.4 | 342.0 | · |
Efficiency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.6 | · | |
| Inventory Turnover | 1.1 | 1.7 | 2.1 | 2.0 | 1.4 | 2.2 | 2.6 | 2.1 | · | |
| Receivables Turnover | 1.0 | 1.3 | 1.5 | 0.8 | 0.7 | 1.1 | 1.3 | 2.1 | · |
Per Share
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $31.01 | $1.12 | $6.28 | $1.28 | $8.09 | $1.03 | $0.27 | $0.49 | · | |
| Revenue / Share | $1.67 | $1.22 | $2.22 | $0.30 | · | · | · | $0.34 | · | |
| Cash Flow / Share | $-5.91 | $-1.65 | $-2.22 | $-0.01 | · | · | · | $0.01 | · | |
| Cash / Share | $29.41 | $1.31 | $5.44 | $1.52 | $7.64 | $0.86 | $0.21 | $0.40 | · | |
| EPS (TTM) | $-9.13 | $-348.17 | $-4285.66 | $-177.84 | $-137.92 | $-3.82 | · | $0.07 | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $2M | $2M | $2M | $3M | $5M | $5M | $7M | · | |
| Net Income TTM | $-6M | $-3M | $-3M | $-6M | $-6M | $-3M | $-10M | $2M | · | |
| Market Cap | $2M | $34M | $4M | $81M | $14M | $714M | $1.94B | $15.49B | · | |
| Enterprise Value | $-26M | $17M | $-8M | $64M | $-1M | $701M | $1.93B | $15.48B | · | |
| P/E | -0.2 | -0.0 | -0.0 | -0.0 | -0.1 | -12.0 | · | 9093.3 | · | |
| P/S | 1.4 | 19.7 | 1.9 | 41.2 | 5.5 | 149.5 | 376.1 | 2208.5 | · | |
| P/B | 0.1 | 2.2 | 0.3 | 5.5 | 0.9 | 44.7 | 206.5 | 1394.2 | · | |
| P / Tangible Book | 0.1 | 2.2 | 0.3 | 5.5 | 0.9 | 44.9 | · | · | · | |
| P / Cash Flow | -0.4 | -14.6 | -1.9 | -1005.3 | 53.0 | -542.4 | 2078.0 | 64742.8 | · | |
| P / FCF | · | · | · | · | · | · | 2416.4 | -52205.8 | · | |
| EV / EBITDA | 3.6 | -6.6 | 3.3 | -12.0 | 0.3 | -378.5 | -1916.4 | 8746.6 | · | |
| EV / FCF | · | · | · | · | · | · | 2407.4 | -52175.8 | · | |
| EV / Revenue | -22.5 | 9.8 | -4.0 | 32.5 | -0.5 | 146.7 | 374.7 | 2207.2 | · | |
| Earnings Yield | -543.5% | -13954.7% | -255098.8% | -2504.8% | -1970.3% | -8.3% | · | 0.01% | · |
Per Share
| Metric | Trend | Q4 2019 |
|---|---|---|
| EPS (TTM) | $0.07 |
Valuation (TTM)
| Metric | Trend | Q4 2019 |
|---|---|---|
| Revenue TTM | $7M | |
| Net Income TTM | $2M | |
| P/E | 9093.3 | |
| Earnings Yield | 0.01% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Revenue | $1M | $2M | $2M | $2M | $3M |
| Gross Margin % | 21.9% | 21.1% | 28.7% | 21.6% | 48.1% |
| Operating Margin % | -625.9% | -154.0% | -130.4% | -284.4% | -199.4% |
| Net Income | $-6M | $-3M | $-3M | $-6M | $-6M |
| Diluted EPS | $-9.13 | $-348.17 | $-4285.66 | $-177.84 | $-137.92 |
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Current Ratio | 7.9 | 3.5 | 1.6 | 1.3 | 1.3 |
| Quick Ratio | 6.7 | 3.2 | 1.5 | 1.3 | 1.1 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 3 filers · $6 total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
3
Value held
$6
New positions
0
Exited positions
1
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 | 1 | 1 | 0 | · |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | $4 | 2 | 66.67% | Shares |
| UBS Group AG | $2 | 1 | 33.33% | Shares |
| ROYAL BANK OF CANADA | $0 | 13 | 0.00% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Feng Zhou, Zhijun Xiao ×2 filings | Jan. 30, 2023 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Jul 1, 2026